Immunol. peptides (APs) and proteins present within the airway surface make up the protective front side (22, 39). Probably the most abundant antibacterial providers in the airways are lysozyme and lactoferrin, which are secreted by submucosal glands, surface epithelia, and neutrophils (3, 22, 70). Additional peptides found in the airway liquid are -defensins, -defensins (BDs), and cathelicidins (3). Several human being BDs (hBDs) have been identified, of which hBD1 (DEFB1), hBD2 (DEFB4), and hBD3 (DEFB3) are the most analyzed (35, 63). BDs display antimicrobial activity against Gram-negative and Gram-positive bacteria, fungi, and viruses. hBD3 appears to be the most potent hBD, since it kills a broad range of microbes at low peptide concentrations. Moreover, in contrast to hBD1 and hBD2, hBD3 displays potent antimicrobial activity Sodium phenylbutyrate at physiological salt concentrations (46, 57). Each hBD has CRF2-9 a unique manifestation profile. hBD1 is definitely constitutively indicated by epithelial cells lining the respiratory tract (47), whereas the manifestation of hBD2 and hBD3 by airway epithelial cells is definitely induced by cytokines or by the presence of pathogens (27, 28, 47, 66). Therefore, hBD2 and hBD3 play an important role in sponsor defense as inducible components of the epithelial barrier. Indeed, hBD2 and hBD3 levels increase severalfold in the lung during pneumonia (29, 33). The importance of BDs in lung defense has been founded by the use of knockout mice. Animals lacking mouse BD1 (mBD1) display a defect in the ability to clear from your lungs (49). However, BDs not only protect the lung against invading microbes but also modulate the sponsor immune response by providing an interface between innate and adaptive immune reactions (64, 76-78). is one of the most common pathogens causing community-acquired respiratory infections, which are particularly devastating in immunocompromised individuals (58, 62). Community-acquired pneumonia is definitely a very severe illness with a rapid onset. Despite the availability of an adequate antibiotic regimen, the outcome is definitely often fatal, with observed mortality rates around 50%. The high prevalence of multidrug-resistant isolates further complicates the treatment of these infections (69). Capsule polysaccharide (CPS) is recognized as probably one of the most important virulence factors of this pathogen. CPS mutants are unable to colonize pulmonary and systemic cells (13, 41, 42). studies have shown that the presence of CPS inhibits Sodium phenylbutyrate the deposition of the match component C3 onto the bacterium (5, 12, 16) and reduces adhesion and phagocytosis of the bacterium by macrophages and epithelial cells (12, 13, 18, 54). Taken together, these findings suggest that CPS takes on an important part in the interplay between and the innate immune system. Recently we have started to study whether expresses mechanisms of resistance against APs. We have demonstrated that surface-bound CPS may act as a protecting shield within the bacterial surface against APs (8), whereas released CPS traps APs, therefore obstructing their bactericidal activity (45). Moreover, sublethal concentrations of APs induce an increase in the transcription of the operon, Sodium phenylbutyrate which correlates with an increase in the amount of surface-bound CPS (8). Concentrations of APs in infected tissues (for example, those found in the surface liquid lining the airway epithelium) could be rather high due to the improved production of APs after acknowledgement of the pathogen. Consequently, although is definitely endowed with mechanisms against APs, these high levels of APs may render these bacterial countermeasures ineffective. Here we explored the possibility that as a strategy for survival in the lung, may not activate the manifestation of hBDs by airway epithelial cells. We present evidence indicating that wild-type bacteria do not induce the manifestation of BDs Sodium phenylbutyrate or CPS mutant engages Toll-like receptors 2 and 4 (TLR2 and TLR4) to induce the manifestation of hBD2, whereas the manifestation of hBD3 is dependent within the activation of NOD1. Finally, we investigate whether you will find negative mechanisms regulating the manifestation of hBDs induced by a CPS mutant. MATERIALS AND METHODS Bacterial strains, growth conditions, and reagents. 52145 is definitely a medical isolate (serotype O1:K2) that has been explained previously (50). The isogenic mutants 52145-for 5 min. After 2 h of illness, cells were washed three.